Among 2019 top 10 Biotech IPOs Genmab's $505 million came #1, while BridgeBio Pharma, Gossamer Bio, Alector and BioNTech also joined the billion-plus valuation club.
Half of top IPOs were cancer-focussed, followed by genetic diseases.
2020 forecast remains uncertain, for now.
Comentarios